ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sevoflurane (Sevoflurane Source) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-10Q9169
Home | Market Reports | Health| Pharmacy
Global Sevoflurane Sevoflurane Source Market Size Status and Forecast 2022
BUY CHAPTERS

Global Sevoflurane (Sevoflurane Source) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-10Q9169
Report
July 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
Hengrui
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma

Sevoflurane (Sevoflurane Source) Market Size

In 2024, the global market size of Sevoflurane (Sevoflurane Source) was estimated to be worth US$ 1195 million and is forecast to reach approximately US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.

Sevoflurane (Sevoflurane Source) Market

Sevoflurane (Sevoflurane Source) Market

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sevoflurane (Sevoflurane Source), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane (Sevoflurane Source).
The Sevoflurane (Sevoflurane Source) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sevoflurane (Sevoflurane Source) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane (Sevoflurane Source) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Sevoflurane (Sevoflurane Source) Market Report

Report Metric Details
Report Name Sevoflurane (Sevoflurane Source) Market
Forecasted market size in 2031 approximately US$ 1527 million
CAGR 3.6%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Sevoflurane (Sevoflurane Source) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Sevoflurane (Sevoflurane Source) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane (Sevoflurane Source) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Sevoflurane (Sevoflurane Source) Market size in 2031?

Ans: The Sevoflurane (Sevoflurane Source) Market size in 2031 will be approximately US$ 1527 million.

Who are the main players in the Sevoflurane (Sevoflurane Source) Market report?

Ans: The main players in the Sevoflurane (Sevoflurane Source) Market are Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma

What are the Application segmentation covered in the Sevoflurane (Sevoflurane Source) Market report?

Ans: The Applications covered in the Sevoflurane (Sevoflurane Source) Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Sevoflurane (Sevoflurane Source) Market report?

Ans: The Types covered in the Sevoflurane (Sevoflurane Source) Market report are Original Drugs, Generic Drugs

Recommended Reports

Inhaled Anesthetics

General Anesthesia

Anesthesia Delivery Devices

1 Study Coverage
1.1 Sevoflurane (Sevoflurane Source) Product Introduction
1.2 Market by Type
1.2.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sevoflurane (Sevoflurane Source) Market Size Estimates and Forecasts
2.1.1 Global Sevoflurane (Sevoflurane Source) Revenue 2020-2031
2.1.2 Global Sevoflurane (Sevoflurane Source) Sales 2020-2031
2.2 Sevoflurane (Sevoflurane Source) Market Size by Region: 2024 Versus 2031
2.3 Sevoflurane (Sevoflurane Source) Sales by Region (2020-2031)
2.3.1 Global Sevoflurane (Sevoflurane Source) Sales by Region: 2020-2025
2.3.2 Global Sevoflurane (Sevoflurane Source) Sales Forecast by Region (2026-2031)
2.3.3 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2031)
2.4 Sevoflurane (Sevoflurane Source) Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Sevoflurane (Sevoflurane Source) Revenue by Region: 2020-2025
2.4.2 Global Sevoflurane (Sevoflurane Source) Revenue Forecast by Region (2026-2031)
2.4.3 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sevoflurane (Sevoflurane Source) Sales by Type (2020-2031)
3.1.1.1 Global Sevoflurane (Sevoflurane Source) Sales Volume by Type (2020-2031)
3.1.1.2 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2031)
3.1.2 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2031)
3.1.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2031)
3.1.2.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2020-2031)
3.1.3 Sevoflurane (Sevoflurane Source) Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sevoflurane (Sevoflurane Source) Sales by Application (2020-2031)
3.2.1.1 Global Sevoflurane (Sevoflurane Source) Sales Volume by Application (2020-2031)
3.2.1.2 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2031)
3.2.2 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2031)
3.2.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2031)
3.2.2.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2031)
3.2.3 Sevoflurane (Sevoflurane Source) Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Original Drugs of Sevoflurane (Sevoflurane Source) Revenue Market Share by Application
3.3.2 Generic Drugs of Sevoflurane (Sevoflurane Source) Revenue Market Share by Application
4 Global Sevoflurane (Sevoflurane Source) by Manufacturers
4.1 Global Top Sevoflurane (Sevoflurane Source) Manufacturers by Sales (2020-2025)
4.1.1 Global Sevoflurane (Sevoflurane Source) Sales by Manufacturer (2020-2025)
4.1.2 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Sevoflurane (Sevoflurane Source) Manufacturers by Revenue (2020-2025)
4.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Manufacturer (2020-2025)
4.2.2 Global Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturer (2020-2025)
4.3 Global Sevoflurane (Sevoflurane Source) Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Sevoflurane (Sevoflurane Source) Manufacturers Covered: Ranking by Revenue
4.4.2 Global Sevoflurane (Sevoflurane Source) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Sevoflurane (Sevoflurane Source) Manufacturing Base Distribution, Product Type
4.5.1 Sevoflurane (Sevoflurane Source) Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Sevoflurane (Sevoflurane Source) Market
4.5.3 Manufacturers Sevoflurane (Sevoflurane Source) Product Type and Application
4.5.4 Original Drugs Market Sales of Sevoflurane (Sevoflurane Source) by Manufacturer
4.5.5 Generic Drugs Market Sales of Sevoflurane (Sevoflurane Source) by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hengrui
5.1.1 Hengrui Company Information
5.1.2 Hengrui Description, Business Overview
5.1.3 Hengrui Sevoflurane (Sevoflurane Source) Products Offered
5.1.4 Hengrui Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Hengrui Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.1.6 Hengrui Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.1.7 Hengrui Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.1.8 Hengrui Recent Developments
5.2 Baxter
5.2.1 Baxter Company Information
5.2.2 Baxter Description, Business Overview
5.2.3 Baxter Sevoflurane (Sevoflurane Source) Products Offered
5.2.4 Baxter Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Baxter Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.2.6 Baxter Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.2.7 Baxter Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.2.8 Baxter Recent Developments
5.3 Maruishi
5.3.1 Maruishi Company Information
5.3.2 Maruishi Description, Business Overview
5.3.3 Maruishi Sevoflurane (Sevoflurane Source) Products Offered
5.3.4 Maruishi Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Maruishi Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.3.6 Maruishi Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.3.7 Maruishi Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.3.8 Maruishi Recent Developments
5.4 AbbVie
5.4.1 AbbVie Company Information
5.4.2 AbbVie Description, Business Overview
5.4.3 AbbVie Sevoflurane (Sevoflurane Source) Products Offered
5.4.4 AbbVie Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.4.5 AbbVie Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.4.6 AbbVie Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.4.7 AbbVie Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.4.8 AbbVie Recent Developments
5.5 Piramal
5.5.1 Piramal Company Information
5.5.2 Piramal Description, Business Overview
5.5.3 Piramal Sevoflurane (Sevoflurane Source) Products Offered
5.5.4 Piramal Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Piramal Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.5.6 Piramal Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.5.7 Piramal Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.5.8 Piramal Recent Developments
5.6 Viatris
5.6.1 Viatris Company Information
5.6.2 Viatris Description, Business Overview
5.6.3 Viatris Sevoflurane (Sevoflurane Source) Products Offered
5.6.4 Viatris Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Viatris Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.6.6 Viatris Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.6.7 Viatris Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.6.8 Viatris Recent Developments
5.7 PT Novell Pharmaceutical
5.7.1 PT Novell Pharmaceutical Company Information
5.7.2 PT Novell Pharmaceutical Description, Business Overview
5.7.3 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Products Offered
5.7.4 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.7.5 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.7.6 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.7.7 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.7.8 PT Novell Pharmaceutical Recent Developments
5.8 Lunan Pharma
5.8.1 Lunan Pharma Company Information
5.8.2 Lunan Pharma Description, Business Overview
5.8.3 Lunan Pharma Sevoflurane (Sevoflurane Source) Products Offered
5.8.4 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales by Product in 2024
5.8.6 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales by Application in 2024
5.8.7 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales by Geographic Area in 2024
5.8.8 Lunan Pharma Recent Developments
6 North America
6.1 North America Sevoflurane (Sevoflurane Source) Market Size YoY Growth 2020-2031
6.2 North America Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
6.2.1 North America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
6.2.2 North America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
6.3 North America Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
6.4 North America Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sevoflurane (Sevoflurane Source) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sevoflurane (Sevoflurane Source) Market Facts & Figures by Region
7.2.1 Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2020-2031)
7.2.2 Asia-Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2031)
7.3 Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
7.4 Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
8 Europe
8.1 Europe Sevoflurane (Sevoflurane Source) Market Size YoY Growth 2020-2031
8.2 Europe Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
8.2.1 Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
8.2.2 Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
8.3 Europe Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
8.4 Europe Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Sevoflurane (Sevoflurane Source) Market Size YoY Growth 2020-2031
9.2 Latin America Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
9.2.1 Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
9.2.2 Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
9.3 Latin America Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
9.4 Latin America Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sevoflurane (Sevoflurane Source) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sevoflurane (Sevoflurane Source) Market Facts & Figures by Country
10.2.1 Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2031)
10.2.2 Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2031)
10.3 Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
10.4 Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sevoflurane (Sevoflurane Source) Supply Chain Analysis
11.2 Sevoflurane (Sevoflurane Source) Key Raw Materials and Upstream Suppliers
11.3 Sevoflurane (Sevoflurane Source) Clients Analysis
11.4 Sevoflurane (Sevoflurane Source) Sales Channel and Sales Model Analysis
11.4.1 Sevoflurane (Sevoflurane Source) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sevoflurane (Sevoflurane Source) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sevoflurane (Sevoflurane Source) Distributors
12 Sevoflurane (Sevoflurane Source) Market Dynamics
12.1 Sevoflurane (Sevoflurane Source) Industry Trends
12.2 Sevoflurane (Sevoflurane Source) Market Drivers
12.3 Sevoflurane (Sevoflurane Source) Market Challenges
12.4 Sevoflurane (Sevoflurane Source) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Baxter
Hengrui
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
List of Tables
 Table 1. Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Sevoflurane (Sevoflurane Source) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Sevoflurane (Sevoflurane Source) Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
 Table 5. Global Sevoflurane (Sevoflurane Source) Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Sevoflurane (Sevoflurane Source) Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Sevoflurane (Sevoflurane Source) Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Sevoflurane (Sevoflurane Source) Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Sevoflurane (Sevoflurane Source) Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Sevoflurane (Sevoflurane Source) Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Sevoflurane (Sevoflurane Source) Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Sevoflurane (Sevoflurane Source) Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Sevoflurane (Sevoflurane Source) Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Sevoflurane (Sevoflurane Source) Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Sevoflurane (Sevoflurane Source) Sales Share by Manufacturer (2020-2025)
 Table 18. Sevoflurane (Sevoflurane Source) Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Sevoflurane (Sevoflurane Source) Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Sevoflurane (Sevoflurane Source) Price (2020-2025) & (US$/Unit)
 Table 21. Ranking of Global Top Sevoflurane (Sevoflurane Source) Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Sevoflurane (Sevoflurane Source) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Sevoflurane (Sevoflurane Source) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane (Sevoflurane Source) as of 2024)
 Table 24. Sevoflurane (Sevoflurane Source) Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Sevoflurane (Sevoflurane Source) Market
 Table 26. Manufacturers Sevoflurane (Sevoflurane Source) Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Hengrui Company Information
 Table 29. Hengrui Description and Business Overview
 Table 30. Hengrui Sevoflurane (Sevoflurane Source) Product
 Table 31. Hengrui Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 32. Hengrui Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 33. Hengrui Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 34. Hengrui Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 35. Hengrui Recent Developments
 Table 36. Baxter Company Information
 Table 37. Baxter Description and Business Overview
 Table 38. Baxter Sevoflurane (Sevoflurane Source) Product
 Table 39. Baxter Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 40. Baxter Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 41. Baxter Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 42. Baxter Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 43. Baxter Recent Developments
 Table 44. Maruishi Company Information
 Table 45. Maruishi Description and Business Overview
 Table 46. Maruishi Sevoflurane (Sevoflurane Source) Product
 Table 47. Maruishi Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 48. Maruishi Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 49. Maruishi Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 50. Maruishi Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 51. Maruishi Recent Developments
 Table 52. AbbVie Company Information
 Table 53. AbbVie Description and Business Overview
 Table 54. AbbVie Sevoflurane (Sevoflurane Source) Product
 Table 55. AbbVie Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 56. AbbVie Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 57. AbbVie Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 58. AbbVie Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 59. AbbVie Recent Developments
 Table 60. Piramal Company Information
 Table 61. Piramal Description and Business Overview
 Table 62. Piramal Sevoflurane (Sevoflurane Source) Product
 Table 63. Piramal Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 64. Piramal Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 65. Piramal Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 66. Piramal Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 67. Piramal Recent Developments
 Table 68. Viatris Company Information
 Table 69. Viatris Description and Business Overview
 Table 70. Viatris Sevoflurane (Sevoflurane Source) Product
 Table 71. Viatris Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Viatris Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 73. Viatris Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 74. Viatris Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 75. Viatris Recent Developments
 Table 76. PT Novell Pharmaceutical Company Information
 Table 77. PT Novell Pharmaceutical Description and Business Overview
 Table 78. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product
 Table 79. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. PT Novell Pharmaceutical Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 81. PT Novell Pharmaceutical Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 82. PT Novell Pharmaceutical Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 83. PT Novell Pharmaceutical Recent Developments
 Table 84. Lunan Pharma Company Information
 Table 85. Lunan Pharma Description and Business Overview
 Table 86. Lunan Pharma Sevoflurane (Sevoflurane Source) Product
 Table 87. Lunan Pharma Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lunan Pharma Sales Proportion of Sevoflurane (Sevoflurane Source) by Product in 2024
 Table 89. Lunan Pharma Sales Proportion of Sevoflurane (Sevoflurane Source) by Application in 2024
 Table 90. Lunan Pharma Sales Proportion of Sevoflurane (Sevoflurane Source) by Geographic Area in 2024
 Table 91. Lunan Pharma Recent Developments
 Table 92. North America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
 Table 93. North America Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
 Table 94. North America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025) & (K Units)
 Table 97. North America Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
 Table 98. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
 Table 99. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Region (2026-2031) & (K Units)
 Table 100. Asia-Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific Sevoflurane (Sevoflurane Source) Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025) & (K Units)
 Table 103. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
 Table 104. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
 Table 105. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
 Table 106. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025) & (K Units)
 Table 109. Europe Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
 Table 110. Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
 Table 111. Latin America Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
 Table 112. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025) & (K Units)
 Table 115. Latin America Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
 Table 116. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
 Table 117. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Country (2026-2031) & (K Units)
 Table 118. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025) & (K Units)
 Table 121. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
 Table 122. Sevoflurane (Sevoflurane Source) Key Raw Materials, Industry Status and Trend
 Table 123. Sevoflurane (Sevoflurane Source) Key Raw Materials and Upstream Suppliers
 Table 124. Sevoflurane (Sevoflurane Source) Clients Status and Trend
 Table 125. Sevoflurane (Sevoflurane Source) Typical Clients
 Table 126. Sevoflurane (Sevoflurane Source) Distributors
 Table 127. Sevoflurane (Sevoflurane Source) Market Trends
 Table 128. Sevoflurane (Sevoflurane Source) Market Drivers
 Table 129. Sevoflurane (Sevoflurane Source) Market Challenges
 Table 130. Sevoflurane (Sevoflurane Source) Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Sevoflurane (Sevoflurane Source) Product Picture
 Figure 2. Global Sevoflurane (Sevoflurane Source) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type in 2024 & 2031
 Figure 4. Original Drugs Product Picture
 Figure 5. Generic Drugs Product Picture
 Figure 6. Global Sevoflurane (Sevoflurane Source) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinics
 Figure 10. Other
 Figure 11. Sevoflurane (Sevoflurane Source) Report Years Considered
 Figure 12. Global Sevoflurane (Sevoflurane Source) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Sevoflurane (Sevoflurane Source) Market Size 2020-2031 (US$ Million)
 Figure 14. Global Sevoflurane (Sevoflurane Source) Sales 2020-2031 (K Units)
 Figure 15. Global Sevoflurane (Sevoflurane Source) Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2031)
 Figure 17. Global Sevoflurane (Sevoflurane Source) Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Sevoflurane (Sevoflurane Source) Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Sevoflurane (Sevoflurane Source) Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
 Figure 20. Global Sevoflurane (Sevoflurane Source) Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Sevoflurane (Sevoflurane Source) Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Sevoflurane (Sevoflurane Source) Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
 Figure 23. Original Drugs of Sevoflurane (Sevoflurane Source) Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Generic Drugs of Sevoflurane (Sevoflurane Source) Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Sevoflurane (Sevoflurane Source) Sales Share by Manufacturer in 2024
 Figure 26. Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Original Drugs Market Sales Proportion by Manufacturer in 2024
 Figure 28. Generic Drugs Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Sevoflurane (Sevoflurane Source) Revenue 2020-2031 (US$ Million)
 Figure 30. North America Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
 Figure 31. North America Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Sevoflurane (Sevoflurane Source) Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
 Figure 37. Europe Sevoflurane (Sevoflurane Source) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
 Figure 39. Europe Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
 Figure 41. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Sevoflurane (Sevoflurane Source) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
 Figure 52. Sevoflurane (Sevoflurane Source) Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Sevoflurane (Sevoflurane Source) Raw Materials by Region in 2024
 Figure 54. Sevoflurane (Sevoflurane Source) Distribution Channels
 Figure 55. Global Sevoflurane (Sevoflurane Source) Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Sevoflurane (Sevoflurane Source) Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Sevoflurane Market Research Report 2024
Global Medical Sevoflurane Market Research Report 2024
Global Sevoflurane Anesthesia Drugs Market Research Report 2024
Global Inhalation Sevoflurane Anesthesia Drugs Market Research Report 2024
Global Sevoflurane For Inhalation Market Research Report 2024
Global Sevoflurane Source Market Insights Forecast to 2030
Global Desflurane Market Research Report 2024
Inhalation Sevoflurane Anaesthetic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalation General Anesthesia Drugs Market Research Report 2024
Global Inhalation Anesthesia Drugs Market Research Report 2024
Global Anesthesia Gas Market Research Report 2024
Global Isoflurane Anesthesia Drugs Market Research Report 2024
Global Inhalational Isoflurane Market Research Report 2024
Sevoflurane Anesthesia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalational Anaesthesia Drugs Market Research Report 2024
Global Sevoflurane and Desflurane Anaesthetics Market Research Report 2025
Global Inhalation Sedatives Market Research Report 2024
Global Sevoflurane Anesthesia Vaporizers Market Research Report 2024
Global Medical Sevofluran Market Research Report 2025
Global General Anesthesia Drugs Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions